Skip Nav Destination
1-9 of 9
Seda Beyhan Sagmen, Sevda Comert, Esra Turan Erkek, Aysun Küçüköz Uzun, Coşkun Doğan, Guven Yılmaz, Nesrin Kıral, Ali Fidan, Çağla Yılmaz Haksal, Elif Torun Parmaksız
Acta Haematol (2019) 142 (3): 171–175.
Published Online: 27 August 2019
... and Hodgkin’s lymphoma (HL). The major limitation of bleomycin therapy is the potential for life-threatening interstitial pulmonary fibrosis. Early identification of asymptomatic patients who may develop toxicity is important. We aimed to evaluate fluorodeoxyglucose positron-emission tomography (FDG-PET/CT...
Acta Haematol (2020) 143 (2): 176–180.
Published Online: 05 June 2019
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Energy drink Thrombotic thrombocytopenic purpura Toxicity Case report...
Acta Haematol (2019) 141 (3): 138–145.
Published Online: 15 February 2019
... not change over the last 40 years and remained in the range of 6–7 months. The definition of elderly is nonuniform, and chronological age is not the best marker of treatment tolerability or a predictor of treatment-related toxicity. Some patients who are fit can tolerate induction, consolidation, and even...
Acta Haematol (2019) 141 (2): 84–90.
Published Online: 10 January 2019
.... The median progression-free survival (PFS) was 47 days (range 12–1,318), the median overall survival (OS) was 1.9 years. Twenty patients (49%) died during follow-up. Grade 3–4 hematological toxicity was reported in 21 patients (51%). Relapsed vs. refractory disease, as well as a response to gemcitabine...
Flávio Augusto Naoum, Breno Pannia Espósito, Lílian Piron Ruiz, Milton Artur Ruiz, Paula Yurie Tanaka, Juliana Tavora Sobreira, Rodolfo Delfini Cançado, José Carlos de Barros
Acta Haematol (2014) 131 (4): 222–226.
Published Online: 05 December 2013
... transplantation (HSCT). There is a concern that labile plasma iron (LPI), the redox-active form of iron, can be involved in the occurrence of toxicity and other complications commonly observed in the early post-HSCT period. In order to better understand the LPI kinetics and its determinants and implications, we...
Acta Haematol (2013) 131 (1): 50–58.
Published Online: 19 September 2013
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Granulocyte transfusions Immunosuppression Infection-attributed deaths Leukemia Life-threatening infections Toxicity Responses to and failure of therapy...
Acta Haematol (1987) 78 (Suppl. 1): 136–138.
Published Online: 25 February 2009
... intraperitoneal P388 and L1210 leukaemias and a variety of solid tumours. Three sequential studies to examine the activity, toxicity and scheduling of MTZ in acute leukaemia or chronic granulocytic leukaemia in myeloid transformation were undertaken in relapsed and/or refractory disease in patients up to the age...
Acta Haematol (1994) 91 (1): 10–15.
Published Online: 18 February 2009
...Ernest Beutler; James A. Koziol; Robert McMillan; Jack C. Sipe; John S. Romine; Carlos J. Carrera 2-Chlorodeoxyadenosine (cladribine, Leustatin®) is being used extensively in the treatment of hematologic malignancies, but relatively little is known regarding its toxicity to the normal marrow. Long...
Acta Haematol (1998) 99 (3): 133–137.
Published Online: 11 April 1998
... results appear to parallel results obtained with post-remission therapies intensified with high-dose cytarabine. These studies provide clinical evidence that intensified induction with cytarabine in AML influences subsequent outcome but is more toxic, gives more profound myelosuppression post-remission...